
Modular Immunoglobulins Boost T-Cell Activation in Her2 Therapy

Domain-exchanged complete antibody composed of the Fc fragment and variable domains where CH1 and CL domains have been exchanged for a pair of CH3 domains.
Modular immunoglobulins composed of Fab-like fragment with HerceptinVL and VH region and CH3 domains and an unmodified Fc fragment are described. Novel is an increased binding to FcR³III, which leads to potentiated T-cell activation upon binding to a Her2-positive cell line
Further information: PDF
Wissenstransferzentrum Ost (WTZ Ost)
Phone: +43 1 401 60 25 202
Contact
Dr. Michael Hoschitz
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.